Login to Your Account



Low IPO Pricing Trend Continues

Acadia, Critical Therapeutics Price In 'Not A Robust Market'

By Aaron Lorenzo


Friday, May 28, 2004
Two more biotech companies went public Thursday, but as has been the case lately, their offerings brought in less than first expected. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription